Sunshine Lake Pharma Co., Ltd.
Sunshine Lake Pharma is a Dongguan-based, Hong Kong-listed (HKEX: 6887) drugmaker. Its antiviral emitasvir phosphate (Dongweien), used in hepatitis C, is approved in China.
| Headquarters | Dongguan, China |
|---|---|
| Listing | HKEX:06887 |
| Lead asset / stage | emitasvir phosphate (Dongweien) Approved — China |
| Latest event | Sunshine Lake Pharma announced a change of company secretary, authorized representative and process agent. |